NEW
DELHI: The European Patent Office (EPO) has, in principle, agreed
to make a conscious effort to block anyone from stealing patents
on India’s traditional knowledge in medicine. This will ensure
that instances like the patenting of turmeric’s medicinal
property in the US, does not occur in the 30-member superstate.
India had, earlier, spent $ 6 million to bust the US patent on turmeric.
A non-disclosure agreement between the union science and technology
ministry and the EPO is expected soon, which will give EPO access
to a digital database of at least 136,000 traditional Indian medicines.
EPO will protect this highly-valuable information and refer it routinely
while reviewing patent applications where the innovation is of botanical
origin.
This would make it easy for the EPO to reject patent requests where
centuries-old knowledge is passed off as innovation.
The National Institute of Science Communication and Information
Resources (NISCIR) under the science and technology ministry is
developing the nearly one-crore page digital database of Ayurveda,
Sidha and Unani medicines.
This project of the Department of Ayurveda, Unani, Sidha, Homoeopathy
and Yoga (Ayush) has been approved by the Department of Industrial
Policy and Promotion (DIPP) and the draft agreement is now being
vetted by the law ministry.
NISCIR is representing the government in negotiations with various
patent offices including those in the US, UK, Japan and Sweden.
Once the agreement with the EPO is signed, it will be able to strongly
persuade the US patent office, which, according to a 2003 study,
has inappropriately granted nearly 380 patents involving India’s
traditional knowledge and biological resources.
Such individual agreements with national patent offices is an interim
arrangement till India is able to persuade the member nations of
the World Intellectual Property Organisation (WIPO) to agree for
a legal framework to protect traditional knowledge and biological
resources, said an official.
Protecting traditional knowledge and biological resources is not
in the purview of the patent system, which provides incentives only
for innovation.
This is addressed by the Convention on Biodiversity. India has,
however, made non-disclosure of the biological source of an innovation
a ground for rejecting a patent. It wants other countries to follow
suit. India is expected to make a major push for this framework
at WIPO’s coming June meeting in Geneva.
|